Massachusetts Institute of Technology
Sign in | Create Account

From Lab to Market: Where Technology is Headed

09/29/2004 9:45 AM Kresge
Rebecca M. Henderson, '81, Eastman Kodak LFM Professor of Management; Paul Horn, Senior Vice President and Director; IBM Research ; Uma Chowdhry, PhD '76, Vice President, Global Central Research and Development; DuPont ; ; Robert Tepper, President, Research and Development ; Millennium Pharmaceuticals

Description: How do you conduct R&D in a vanguard technology? These three panelists provide varying perspectives on the question. Paul Horn stands by IBM's longstanding commitment to its 5.5 billion dollar annual research effort, but with some caveats: "It's all about the speed of flowing new ideas into hardware, software and services," he says. You can't think about innovation without also considering "channels to market." IBM insists that "researchers spend time in the marketplace so they can understand how their technology can solve real world problems."

At DuPont, Uma Chowdhry cites a "quietly occurring transformation in the area of biobased materials." At two centuries' young, DuPont has a new primary challenge: "How do we transform from a petroleum-based economy to renewable resources such as crops?" Working with partners such as MIT, the company is exploring glucose, methane and nanotechnology to cook up new kinds of fuel, food supplements, and other products all economically. It's "a very big dream," acknowledges Chowdhry. The prerequisite, she says, is that "top management must have an unwavering commitment to the mission as well as time, vision and patience."

Robert Tepper describes the convergence of two revolutions driving his field forward. The complete sequencing of the human genome, combined with advances in understanding pathways of disease, will enable Millennium's researchers to create "breakthrough therapies." Scientists are already "making strides in cancer and inflammation," says Tepper. Millennium is linking up with industry, hospitals and academia, plumbing the genome to learn "why individuals are susceptible to disease."

Host(s): Office of the Provost, Technology Review

Tape #: 19004

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments. If you don’t have an account yet, sign up now!

MIT World — special events and lectures

MIT World — special events and lectures

Category: Events | Updated over 2 years ago

Created
December 12, 2011 19:31
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
1938 times

More from MIT World — special events and lectures

Academic Perspectives/Panel Discussion

Academic Perspectives/Panel Discussion

Added over 2 years ago | 01:03:00 | 1525 views

Emotion Machine: Commonsense Thinking, Artificial Intelligence, and the Future of the Human Mind

Emotion Machine: Commonsense Thinki...

Added over 2 years ago | 01:24:00 | 2465 views

Volvo's Environmental Business Strategy

Volvo's Environmental Business Stra...

Added over 2 years ago | 01:24:00 | 1292 views

Democratizing Innovation

Democratizing Innovation

Added over 2 years ago | 01:00:00 | 2080 views

The Blank Slate: The Modern Denial of Human Nature

The Blank Slate: The Modern Denial ...

Added over 2 years ago | 01:52:00 | 2230 views

Standards and Strategy: Competing in Increasingly Open Worlds

Standards and Strategy: Competing i...

Added over 2 years ago | 00:55:30 | 1922 views